Across TCGA pan-cancer cohorts, PWWP2A mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of PWWP2A’s most consistent transcriptional readouts.
The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where PWWP2A mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types PWWP2A is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.
CCRCC, LUAD, and PDAC are the cancer types where PWWP2A tumor–normal differential expression is most reproducible.